+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "RNA Interference"

Investor Series: Opportunities in RNA Therapeutics Market - Product Thumbnail Image

Investor Series: Opportunities in RNA Therapeutics Market

  • Report
  • March 2023
  • 174 Pages
  • Global
From
Viral Vectors & Plasmid DNA Manufacturing Market Report 2024-2034 - Product Thumbnail Image

Viral Vectors & Plasmid DNA Manufacturing Market Report 2024-2034

  • Report
  • December 2023
  • 408 Pages
  • Global
From
RNA Based Therapeutics and Vaccines Market Report 2022-2032 - Product Thumbnail Image

RNA Based Therapeutics and Vaccines Market Report 2022-2032

  • Report
  • October 2022
  • 213 Pages
  • Global
From
From
From
RNAi Drug Delivery: Technologies and Global Markets - Product Thumbnail Image

RNAi Drug Delivery: Technologies and Global Markets

  • Report
  • August 2023
  • 141 Pages
  • Global
From
Global RNA Analysis Market 2021-2026 - Product Thumbnail Image

Global RNA Analysis Market 2021-2026

  • Report
  • October 2021
  • 55 Pages
  • Global
From
From
Loading Indicator

RNA interference (RNAi) is a biotechnological process that uses small pieces of double-stranded RNA (dsRNA) to inhibit gene expression. It is a powerful tool for studying gene function and has been used to develop treatments for a variety of diseases. RNAi has been used to target and silence specific genes, allowing researchers to study the effects of gene silencing on cell function. It has also been used to develop treatments for cancer, viral infections, and other diseases. RNAi technology has been used to develop a variety of therapeutics, including small interfering RNAs (siRNAs), microRNAs (miRNAs), and antisense oligonucleotides (ASOs). siRNAs are short pieces of dsRNA that can be used to target and silence specific genes. miRNAs are small pieces of single-stranded RNA that can regulate gene expression. ASOs are short pieces of DNA that can be used to target and silence specific genes. The RNAi market is a rapidly growing segment of the biotechnology industry. Companies in the market include Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, BioNTech, Editas Medicine, and Moderna Therapeutics. These companies are developing a variety of RNAi-based therapeutics for a range of diseases. Show Less Read more